-
-
Call more information
660-596-2224 -
Prolonged-release oxycodone / naloxone shows significant efficacy for the reduction of musculoskeletal pain and nocturnal pain for patients with severe pain from Parkinson’s disease compared with placebo, according to results of a double-blind study presented at the First Congress of the European Academy of Neurology (EAN). Prolonged-release oxycodone / naloxone also demonstrated no unanticipated adverse […]
Read MoreThe combination of peri-articular and adductor canal infiltration was superior than peri-articular infiltration alone or adductor canal infiltration alone in decreasing pain when walking on day 1 after a knee replacement, according to a study presented here at the 2015 Annual Meeting of the Canadian Anesthesiologists’ Society (CAS). “Knee surgery is very painful,” said Richard […]
Read MoreThe use of sumatriptan decreases post-operative headache at the non-surgical site in patients who undergo craniotomy for the treatment of trigeminal neuralgia and facial spasms, researchers said here at the 2015 Annual Meeting of the Canadian Anesthesiologists’ Society (CAS). “These patients complain of pain at the non-surgical site as well as nausea and vomiting,” said […]
Read MorePatients who minimally used opioids prior to surgery, but who continued to use them for pain relief 30 days after surgery were likely to be using them in the longer term, according to a study presented here at the 2015 Annual Meeting of the Canadian Anesthesiologists’ Society (CAS). With ongoing opioid use being a public […]
Read MoreSumatriptan is less effective in migraine attacks with aura than in those without, new data reveal. The findings, from an analysis of previous clinical trial results, were presented here at the American Headache Society (AHS) 57th Annual Scientific Meeting by Jakob Møller Hansen, MD, PhD, a resident at the Department of Neurology at Rigshospitalet and […]
Read More